SCHEMBL8832315

SCHEMBL8832315

CS(=O)(=O)c1cc(C(=O)NC(=N)N)ccc1Sc1ccncc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ PLAU P00749 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ SLC9A1 P19634 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8831869 0.82 CA2 (0.42) ALDH1A1CYP1A2CYP3A4CYP2C9TSHR
Hydrochloric Acid SCHEMBL8813834 0.81 CPT2 (0.39) ALDH1A1LMNAMAPTMEN1KMT2A
SCHEMBL9192608 0.80 CNR2 (0.36) ALDH1A1LMNAGAAMAPTMEN1
Hydrochloric Acid SCHEMBL8816372 0.80 CNR2 (0.38) ALDH1A1MAPTPTGS2
Hydrochloric Acid SCHEMBL8813468 0.80 ICAM1 (0.36) ALDH1A1LMNASMN1; SMN2MAPTPKM
SCHEMBL8831854 0.79 KDM4E (0.49) PDE7AALDH1A1LMNACYP1A2TSHR
SCHEMBL9195550 0.79 LMNA (0.46) ALDH1A1LMNAMAPK1MAPTMEN1
Hydrochloric Acid SCHEMBL8815994 0.79 CNR2 (0.36) ALDH1A1LMNAGAAMAPTMEN1
Hydrochloric Acid SCHEMBL8815741 0.79 ALDH1A1 (0.36) ALDH1A1GAAMEN1KMT2A
SCHEMBL9189602 0.79 CA2 (0.47) GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5665739-A CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1997-09-09 — — US disclosed
EP-0602523-B1 Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them HOECHST AG (DE) 1996-12-11 — — EP disclosed
EP-0602523-A1 Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them HOECHST AKTIENGESELLSCHAFT (DE) 1994-06-22 — — EP disclosed
Send feedback